Senior Segment Marketing Manager- Antibody Drug Discovery, GenScript USA Inc.
BIOGRAPHY
OCT 04, 2023 6:00 AM PDT
Unlocking the Potential of Cancer Therapeutic Antibodies: GenScript's Immune Checkpoint and Therapeutic Antibody Solutions with Live Q&A
Speaker
Abstract
In the ever-evolving landscape of cancer therapy, immune checkpoint inhibitors have emerged as promising avenues for therapeutic antibody development. Our presentation will share GenScript's comprehensive suite of products and services tailored to empower scientists in the field of cancer therapeutic antibody development with emphasis on Immune Checkpoints. Join us as we explore how GenScript's innovative solutions, ranging from antibody generation to bioassay development, protein expression, and beyond, can accelerate your efforts in harnessing the power of immune checkpoint inhibitors to combat cancer.
Learning Objectives:
1. Explore GenScript's custom antibody generation and optimization services tailored for immune checkpoint proteins.
2. Learn about high-quality protein expression services for immune checkpoint studies.
3. Gain insights into cell line development and its role in stable expression of immune checkpoint proteins.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...